Study for the application of Cisatracurium Besilate in orthopedic surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900025301

Enrollment

Unknown

Registered

2019-08-22

Start date

2019-10-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthopaedic surgery

Interventions

group I:Cisatracurium Besilate 40µg/kg

group II:Cisatracurium Besilate 50µg/kg

group III:Cisatracurium Besilate 60µg/kg

group ?:Cisatracurium Besilate 70µg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Orthopedic surgery patient.

Exclusion criteria

Exclusion criteria: High blood pressure.

Design outcomes

Primary

Measure	Time frame
Blood drug concentration;	—

Countries

China

Contacts

Public ContactGuo Cheng

Shanghai Jiaotong University Affiliated Sixth People's Hospital

gboss@126.com+86 18930177555

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026